About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Researchers Discover A Potential Target To Treat Idiopathic Pulmonary Fibrosis

by Aruna on August 26, 2009 at 8:49 AM
Font : A-A+

Researchers Discover A Potential Target To Treat Idiopathic Pulmonary Fibrosis

University of Michigan researchers have discovered a potential target that could help treat patients with idiopathic pulmonary fibrosis, a deadly lung disease.

They found that targeting of a novel gene utilizing genetic and pharmacologic strategies was successful in treating pulmonary fibrosis in mice and will be developed for future testing in humans.

Advertisement

The treatments attack an oxidant-generating enzyme, NOX4, that researchers discovered is involved in the fibrotic process - which involves scar-like tissue formation in an organ such as the lung.

"We've identified the target. We know the enemy now. This is the first study that shows pulmonary fibrosis is driven by this NOX4 enzyme," said Subramaniam Pennathur, M.D., assistant professor of internal medicine/nephrology.
Advertisement

"But what's really significant is this discovery may have relevance to fibrosis in other organ systems, not just the lung," Pennathur added.

Pennathur said that those suffering from common cardiac or kidney diseases, which often involve fibrosis, also may benefit from treatments stemming from this research.

The discovery was made in the University of Michigan lab of Victor J. Thannickal, M.D.

Thannickal said the study points to a very viable treatment strategy for idiopathic pulmonary fibrosis, and researchers saw success both in mouse models of lung fibrosis and in fibrogenic cells isolated from lungs of patients with Idiopathic Pulmonary Fibrosis.

"It remains to be seen if fibrosis is reversible. But therapeutic targeting of this pathway this may allow us to halt the progression of fibrosis and preserve lung function," he said.

The findings will be published in the September issue of the journal Nature Medicine.

Source: ANI
ARU
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cochlear Implants may Consequently Drive Hearing Loss
E-cigarettes Use Linked to Erectile Dysfunction
Memory Loss - Can it be Recovered?
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Silicosis Pulmonary Fibrosis 

Recommended Reading
Researchers Identify Therapeutic Target That May Allow To Halt The Progression Of Pulmonary Fibrosis
According to studies a diagnosis of Idiopathic Pulmonary Fibrosis is not much better than a death .....
New Way To Predict Mortality In Patients With Idiopathic Pulmonary Fibrosis
There may be a new way to predict mortality in patients with idiopathic pulmonary fibrosis (IPF), a ...
Genes in Acutely Ill Idiopathic Pulmonary Fibrosis Patients Profiled by Pitt Researchers
A patient-driven effort to provide lung tissue for research may now help doctors predict when ......
Pulmonary Fibrosis
Do you find yourself out of breath and coughing a lot lately? Do you work in dust prone places? Well...
Silicosis
Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterise...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use